A Study to Identify and Characterise Patients with Chronic Kidney Disease and Proteinuria

Exclusion Criteria

• 1 Known NYHA class III or class IV Congestive Heart Failure at the time of enrolment
• 2 Known T1DM
• 3 Known history of any life-threatening cardiac dysrhythmia (continuous or paroxysmal)
• 4 Known history of solid organ transplantation
• 5 Known history or ongoing allergy/hypersensitivity, as judged by the investigator, to SGLT2i (eg, dapagliflozin, canagliflozin, empagliflozin) or endothelin receptor antagonists (eg, ambrisentan, atrasentan, bosentan)
• 6 Known blood-borne diseases such as specified in Appendix B (category A and B)
• 7 Known pregnancy at the time for the visit or have an intention to become pregnant
• 8 Lupus nephritis, anti-neutrophil cytoplasmic autoantibody vasculitis, minimal change disease, autosomal dominant polycystic kidney disease (polycystic kidney disease), Alport syndrome, patients on renal replacement therapy, or clinical nephrotic syndrome with problematic oedema